Katrien Reynders-Frederix
Direttore/Membro del Consiglio presso EconCore NV
Profilo
Katrien Reynders-Frederix is currently a Director at EconCore NV.
Prior to this, she served as the Chief Executive Officer at Pan Cancer T from 2020 to 2023.
Posizioni attive di Katrien Reynders-Frederix
Società | Posizione | Inizio |
---|---|---|
EconCore NV
EconCore NV Miscellaneous ManufacturingProducer Manufacturing EconCore NV specializes in economic sandwich material production technologies. The firm’s products include PP honeycomb panels, composite panels, steel panels, polycarbonate panels, and wood panels. The company was founded in December 2005 by Ignaas Verpoest and Dirk Vandepitte and is headquartered in Leuven, Belgium. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Katrien Reynders-Frederix
Società | Posizione | Fine |
---|---|---|
Pan Cancer T
Pan Cancer T BiotechnologyHealth Technology Pan Cancer T is a company based in Rotterdam, Netherlands that was founded in 2020 by Reno Debets, Dora Hammerl. The Dutch company focuses on advancing next generation TCR T cell therapies for hard-to-treat solid tumors. The company's approach includes exploiting unique targets for T cells that are exclusively and robustly expressed by multiple solid cancers and developing technologies that enhance the durability of the T cells. The company has ongoing R & D programs to develop safe and effective adoptive T cell therapies for patients with triple negative breast cancer as well as cancers of the bladder, ovarium, colorectum, prostate, skin, esophagus, lung, or brain. Rachel Abbott has been the CEO of the company since 2023. | Amministratore Delegato | 12/05/2023 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 2 |
---|---|
EconCore NV
EconCore NV Miscellaneous ManufacturingProducer Manufacturing EconCore NV specializes in economic sandwich material production technologies. The firm’s products include PP honeycomb panels, composite panels, steel panels, polycarbonate panels, and wood panels. The company was founded in December 2005 by Ignaas Verpoest and Dirk Vandepitte and is headquartered in Leuven, Belgium. | Producer Manufacturing |
Pan Cancer T
Pan Cancer T BiotechnologyHealth Technology Pan Cancer T is a company based in Rotterdam, Netherlands that was founded in 2020 by Reno Debets, Dora Hammerl. The Dutch company focuses on advancing next generation TCR T cell therapies for hard-to-treat solid tumors. The company's approach includes exploiting unique targets for T cells that are exclusively and robustly expressed by multiple solid cancers and developing technologies that enhance the durability of the T cells. The company has ongoing R & D programs to develop safe and effective adoptive T cell therapies for patients with triple negative breast cancer as well as cancers of the bladder, ovarium, colorectum, prostate, skin, esophagus, lung, or brain. Rachel Abbott has been the CEO of the company since 2023. | Health Technology |
- Borsa valori
- Insiders
- Katrien Reynders-Frederix